Loading...
Home
Health Systems
Continuing Education
Supplements
Teaching Aids
e-Connect
Archive
Resources
MISCELLANEOUS
19-MINUTE PROMISE
AACP
AAP
AARP
ABRAXIS
ACADEMIC CAREER
ACCREDITATION
ACCURATE
ACHIEVEMENTS
ACID
ACL
ADHERENCE
ADVERSE EVENTS
ALLIGATOR BLOOD
ALMONDS
AMP
ANALGESICS
ANALYZING
ANTIBIOTIC RESISTANCE
ANTIBIOTICS
ANTIOXIDANT
ANTIOXIDANTS
ANTS
APPES
ASTHMA
AVANDIA
AWP
BABY BOOMERS
BACK PAIN
BACK STRAIN
BACKGROUND CHECK
BACTERIA
BLISTERS
BODY FAT
BRAIN HORMONE
CANADA
CANCER
CARDIOVASCULAR
CARDIOVASCULAR DISEASE
CARDIOVASCULAR
DISORDERS
CARDIOVASCULAR RISK
CAREER
CAREER CHANGE
CAREMARK
CERTIFIED TECHNICIAN
CHAIN PHARMACY
CHOLESTEROL
CHOLESTEROL
MEDICATIONS
CLEVELAND CLINIC
CLINICAL
CLINICAL ROTATIONS
CMS
COLD WEATHER
COMMUNITY PHARMACY
COMPETITIVE BIDDING
COMPOUNDING
CONSEQUENCES
CONSUMER
CONTRACEPTION
CONTRACEPTIVES
CORONARY
COUNSELING
CREDITS
CRIMINAL
CVS
CYANOBACTERIA
CYTOKINES
DASATINIB
DAYLIGHT SAVINGS TIME
DEPRESSION
DERMATOLOGY
DHHS
DIABETES
DIARRHEA
DISABILITY
DISPENSE
DISPOSAL
DOCTOR VISITS
DOMINO'S PIZZA
DORIPENEM
DRUG EXTORTION
DRUGS
E COLI
EDUCATION
ERECTILE DYSFUNCTION
ERRORS
ESTROGEN PATCH
ETHICS
ETRAVIRINE
EXTREME COLD
FAST FOOD
FDA
FEMORAL NECK FRACTURE
FEVER
FINANCIAL
FLAT FEET
FLYING
FRAUD
FREE RADICAL
FROSTBITE
FRUIT
FUNGAL DISEASES
GENETICS
GERIATRICS
GLIMEPIRIDE
GRAM-NEGATIVE BACTERIA
GRAPE PLANTS
HEADACHE
HEALTH INSURANCE
HEALTH
POLICY/PUBLIC POLICY
HEALTH RECORDS
HEARING LOSS
HEEL PAIN
HIP FRACTURE
HIPAA
HUNGER
HYPERTENSION
IMPOTENCE
INFLUENZA
INSOMNIA
IN-STORE CLINICS
INSURANCE
INTENSIVE CARE UNIT
INTERNSHIPS
INTERTROCHANTERIC
FRACTURE
IPOD
IXABEPILONE
KNEE INJURY
LASSITUDE
LIABILITY
LICENSE
LIDOCAINE
LIGHTNING STRIKE
LONGEVITY
LUCKY STORES
LUNG
MARAVIROC
MARKETING
MEDICAID
MEDICARE
MEDICARE PART D
MEDICATION ERROR
MEDICATION MANAGEMENT
MEDSTAR
MENISCUS
MERCURY
METHADONE
METHICILLIN-RESISTANT
STAPHYLOCOCCUS AUREUS
MOOD DISORDER
MOOD SWINGS
MORTALITY
MOTION SICKNESS
NACDS
NARCOTICS
NAUSEA
NCPA
NCPDP
NME
OBESE
OBESITY
ONCOLOGY
ONCOLOGY/HEMATOLOGY
OTC COLD MEDICATIONS
OTC MEDICATIONS
PAIN MANAGEMENT
PBM
PHARMACOECONOMICS
PHARMACY DIRECTORS
PHARMACY
DRIVE-THROUGH WINDOWS
PHARMACY LAW
PHARMACY PRACTICE
PHARMACY TECHNICIANS
PHYSICIAN FEE CUTS
PLANTAR FASCIITIS
POLICE
POLICIES
POLYPHENOLS
POSACONAZOLE
PREGNANCY
PRESCRIPTION
PROFESSION
PSYCHOTROPIC DISORDERS
RALTEGRAVIR
RATERS
REGULATORY
REIMBURSEMENT
RESIDENCY
RESPONSIBILITY
RETAIL PHARMACY
RILONACEPT
RITE AID
RPH
RUNNING SHOES
SALMONELLA
SAVE MART
SAVE MART SUPERMARKETS
SENIOR CARE
SEX
SHOCK ABSORPTION
SHOES
SLEEP
SLEEP DISORDERS
SMOKING
SMOKING CESSATION
SMOKING PREVALENCE
SNEAKERS
SNPHA
SORBITOL
STEM CELLS
STEROIDS
STUDENTS
SUBSTITUTION
SUGAR-FREE GUM
SURVEY
TETRACAINE
TEXTBOOKS
THERMOMETER
THUNDERSTORMS
UCONN
SCHOOL OF PHARMACY
UNIVERSAL HEALTH CARE
VETERINARIAN
VORINOSTAT
WALGREENS.
CRYSTAL APPLE AWARD
WASTE
WEIGHT
Loading...
Featured Content
Botox Applications: A Review of Risks and Benefits
3/19/2010
Botox, which is a purified form of the toxin botulinum produced by the bacterium
Clostri
d
ium botulinum
, has several medical applications.
TAGS:
MISCELLANEOUS
FDA Approves Statin for Primary CVD Prevention
3/19/2010
TAGS:
MISCELLANEOUS
More McNeil OTCs Recalled
3/19/2010
TAGS:
MISCELLANEOUS
Walgreens to Acquire Duane Reade
3/19/2010
TAGS:
MISCELLANEOUS
Loading...
Related CE
Opioid Addiction: No Reason to Withhold Pain Management
Delirium in the Elderly: Medications, Causes, and Treatment
Total Cholesterol Management: Taking Complete Control
The Pharmacist's Role in the Appropriate Selection of a Nonprescription Product for Pain Relief
New Guidelines for the Diagnosis and Management of Asthma
Related Content
Opioid Addiction: No Reason to Withhold Pain Management
Delirium in the Elderly: Medications, Causes, and Treatment
Total Cholesterol Management: Taking Complete Control
The Pharmacist's Role in the Appropriate Selection of a Nonprescription Product for Pain Relief
New Guidelines for the Diagnosis and Management of Asthma
Loading...
COMPETITIVE BIDDING
What's News
5/18/2007
FDA Advisory Board Rejects Arthritis Drug Approval Gaithersburg, MD -- The FDA's Arthritis Drugs Advisory Committee voted overwhelmingly to reject approval of Merck's COX-2 inhibitor Arcoxia (etoricoxib).
TAGS:
MISCELLANEOUS
|
CARDIOVASCULAR
|
FDA
|
DIABETES
|
AAP
|
COMPETITIVE BIDDING
Loading...
Advertisement
Loading...
Loading...
Advertisers
Media Kit
Contact Us
Privacy Policy
Editorial Staff
Classifieds
About USP
U.S. Pharmacist is a monthly journal dedicated to providing the nation's pharmacists with up-to-date, authoritative, peer-reviewed clinical articles relevant to contemporary pharmacy practice in a variety of settings, including community pharmacy, hospitals, managed care systems, ambulatory care clinics, home care organizations, long-term care facilities, industry and academia. The publication is also useful to pharmacy technicians, students, other health professionals and individuals interested in health management. Pharmacists licensed in the U.S. can earn Continuing Education credits through Postgraduate Healthcare Education, LLC, accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
Copyright © 2000 - 2010 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.